Poland vs United Kingdom: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Poland
89.0%
in 2025
United Kingdom
89.0%
in 2025
Poland rank
70th
United Kingdom rank
70th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Poland
- United Kingdom
How they compare
Poland currently reports 89.0% against 89.0% in United Kingdom, a difference of 0.0%.
Across all 18 years both countries report, United Kingdom has been ahead every year.
Poland ranks 70th and United Kingdom ranks 70th of 192 countries.
United Kingdom has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Poland | United Kingdom | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 14.9% | 91.7% | 76.8% | United Kingdom |
| 2020s | 88.5% | 89.8% | 1.3% | United Kingdom |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Poland or United Kingdom?
- Poland, at 89.0% against 89.0% in United Kingdom as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Poland and United Kingdom?
- 0.0%, with Poland ahead.
- How many years of comparable data are there for Poland and United Kingdom?
- 18 years are reported by both, from 2008 to 2025.
- How do Poland and United Kingdom rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Poland ranks 70th and United Kingdom ranks 70th of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.